StockData
Kalaris Therapeutics, Inc. logo

Kalaris Therapeutics, Inc. (KLRS) stock

KLRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.43−0.03 (-2.05%)

Close on Nov 17, 2026Market cap $34.04MP/E –Yield –

Kalaris Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Kalaris Therapeutics's operating margin for the twelve months ending Dec 31, 2019 was -16182.4%. For fiscal 2019 it was -16182.4%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 2019-16182.4%–

More Kalaris Therapeutics figures

See a number that looks wrong?